Anders Lindblad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anders Lindblad has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Anna-Maria Dittrich
Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, 30625 Hannover, Germany
1 shared publication - Annalisa Orenti
Department of Clinical Sciences and Community Health, Dipartimento di Eccellenza 2023-2027, Laboratory of Medical Statistics, Biometry and Epidemiology “G.A. Maccacaro”, University of Milan, Milan, Italy
1 shared publication - Birgitta Strandvik
CLINTEC, Karolinska Institutet NOVUM, Stockholm, Sweden
1 shared publication - Carla Colombo
Department of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano, IRCCS, Milan 20145, Italy; Department of Pathophysiology and Transplantation, University of Milan, Milan 20122, Italy
1 shared publication Chee Y. Ooi
Sydney Children's Hospital & School of Women's and Children's Health, Medicine, University of New South Wales, Sydney, Australia
1 shared publication- Clare Saunders
NHLI, Imperial College, London, UK. Royal Brompton and Harefield Hospitals, Guy's and St Thomas' Trust, London, UK. ECFS CTN Central Overreading Centre for Lung Clearance Index
1 shared publication
Latest Publications
- Open Access
- 4 July 2025
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 24 (4) , 669-683
Pulmonary endpoints in clinical trials for children with cystic fibrosis under two years of age
- 4 July 2025
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 24 (4) , 669-683
Open AccessPulmonary endpoints in clinical trials for children with cystic fibrosis under two years of age
- 2 February 2023
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 22 (2) , 263-265
Characterization of CFTR mutations in people with cystic fibrosis and severe liver disease who are not eligible for CFTR modulators
- 2 February 2023
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 22 (2) , 263-265
Characterization of CFTR mutations in people with cystic fibrosis and severe liver disease who are not eligible for CFTR modulators
- 28 August 2022
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 22 (1) , 103-111
Prevalence, trends and outcomes of long-term inhaled antibiotic treatment in people with cystic fibrosis without chronic Pseudomonas aeruginosa infection – A European cystic fibrosis patient registry data analysis
- 28 August 2022
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 22 (1) , 103-111
Prevalence, trends and outcomes of long-term inhaled antibiotic treatment in people with cystic fibrosis without chronic Pseudomonas aeruginosa infection – A European cystic fibrosis patient registry data analysis
- 1 July 2021
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 131 (1) , 107-118
Improved agreement between N2 and SF6 multiple-breath washout in healthy infants and toddlers with improved EXHALYZER D sensor performance
Modern nitrogen multiple-breath washout (N2MBW) systems such as EXHALYZER D use O2 and CO2 sensors to calculate N2 concentrations. New corrections for interactions between high O2 and CO2 concentrations on the gas sensors now provide accurate N2 signals. The correct N2 signal led to much improved agreement between N2MBW and sulfur hexafluoride (SF6) MBW functional residual capacity (FRC) and lung clearance index (LCI) in 52 sleeping healthy infants and toddlers, suggesting a role for N2MBW in this age-group.
- 1 July 2021
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 131 (1) , 107-118
Improved agreement between N2 and SF6 multiple-breath washout in healthy infants and toddlers with improved EXHALYZER D sensor performance
Modern nitrogen multiple-breath washout (N2MBW) systems such as EXHALYZER D use O2 and CO2 sensors to calculate N2 concentrations. New corrections for interactions between high O2 and CO2 concentrations on the gas sensors now provide accurate N2 signals. The correct N2 signal led to much improved agreement between N2MBW and sulfur hexafluoride (SF6) MBW functional residual capacity (FRC) and lung clearance index (LCI) in 52 sleeping healthy infants and toddlers, suggesting a role for N2MBW in this age-group.
- Open Access
- 10 January 2011
- Published by Wolters Kluwer Health in Hepatology
- Vol. 53 (3) , 1064-1065
Noncirrhotic Presinusoidal Portal Hypertension Is Common in Cystic Fibrosis–Associated Liver Disease Δ
- 10 January 2011
- Published by Wolters Kluwer Health in Hepatology
- Vol. 53 (3) , 1064-1065
Open AccessNoncirrhotic Presinusoidal Portal Hypertension Is Common in Cystic Fibrosis–Associated Liver Disease Δ
- 1 January 1998
- Published by Springer Nature
- p. 178
Over-Expression of Ferredoxin I in Rhodospirillum rubrum using the NifH Promoter
- 1 January 1998
- Published by Springer Nature
- p. 178
Over-Expression of Ferredoxin I in Rhodospirillum rubrum using the NifH Promoter